P
PathoQuest
Biotech & Life Sciences · Paris, France · Founded 2010
PathoQuest is a biotechnology company identifying pathogens through High Throughput Sequencing (HTS). MoreLess
PathoQuest operates in the biologics sector, providing genomic services that focus on pathogen detection to enhance clinical decision-making. The company serves clients in the pharmaceutical and biotechnology industries, particularly those involved in cell and gene therapy products. PathoQuest's business model revolves around offering specialized testing services that ensure the safety and efficacy of biological drugs. By obtaining Pharmaceutical Establishment status from the French ANSM, PathoQuest has solidified its position in the market, allowing it to conduct comprehensive biological drug testing activities. The company generates revenue through service contracts with biopharma companies, aiming to improve the safety of biologics and accelerate their time to market. PathoQuest's participation in industry events like BioProcess International Europe and BioPharma Asia webinars highlights its commitment to staying at the forefront of viral safety and pathogen detection advancements. Keywords: biologics, genomic services, pathogen detection, clinical decision-making, pharmaceutical, biotechnology, cell therapy, gene therapy, drug testing, viral safety
Company overview
PathoQuest company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2010
- Headquarters
- Paris, France
- Employees
- 59
- Open positions
- 1
- Dealroom signal
- 72.2
Valuation & funding
PathoQuest funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2026 | $0 | — | Charles River Laboratories International | ↗ |
| SERIES B✓Equity / VC | Nov 2021 | $17M | $66M | Turenne Capital · Eurazeo · SHS Capital · Verve Ventures | ↗ |
| SERIES A✓Equity / VC | Sep 2019 | $8.8M | $35M | Eurazeo · Verve Ventures · Charles River Laboratories International · Kurma Partners | — |
| EARLY VC✓Equity / VC | May 2018 | $4.4M | $18M | Kurma Partners · Eurazeo · Aurinvest | — |
| EARLY VCEquity / VC | Jul 2015 | $2.2M | $8.8M | Kurma Partners | — |
| EARLY VC✓Equity / VC | Jul 2013 | Kurma Partners · Eurazeo · Aurinvest | — | ||
| EARLY VC✓Equity / VC | Mar 2011 | Undisclosed | — | ||
| SPINOUT✓Other financing | Jan 2011 | Institut Pasteur | ↗ |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
Growth signals
PathoQuest website traffic
Latest recorded traffic for PathoQuest is 1K monthly website visits, down 37.5% over the last three months. PathoQuest's team declined 4.8% over the past year.
Hiring
Open positions at PathoQuest
Current openings linked to this company in Dealroom.
Comparisons
PathoQuest compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
PathoQuest's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where PathoQuest has talent and traffic
team presence
In the news
Latest news about PathoQuest
Recent press, funding announcements, and product moves mentioning PathoQuest — open to read from the original sources.
Market sentiment
What the market is saying about PathoQuest
An AI-synthesized read of the highest-engagement posts about PathoQuest on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PathoQuest’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.